Literature DB >> 16862317

Seroepidemiology of hepatitis B virus infection and high rate of response to hepatitis B virus Butang vaccine in adolescents from low income families in Central Brazil.

Michele Dias da S Oliveira1, Regina M B Martins, Marcos A Matos, Renata C Ferreira, Márcia A Dias, Megmar A S Carneiro, Ana Luiza N Junqueira, Sheila A Teles.   

Abstract

In order to evaluate the seroepidemiology and response to Butang vaccine in adolescents from low income families in Central Brazil, blood samples of 664 adolescents were tested for hepatitis B surface antigen (HBsAg), hepatitis B core antibody (anti-HBc), and hepatitis B surface antibody (anti-HBs) markers, and multiple logistical regression analysis was carried out to determine variables associated with hepatitis B virus (HBV) infection markers. further, three 20 microg Butang vaccine doses were offered to all susceptible individuals (n = 304). Among those who accepted them (n = 182), the seroresponse was evaluated in 170 individuals by quantitative anti-HBs. an overall hbv prevalence of 5.9% was found: four adolescents were HBsAg positive, 24 were anti-HBc, anti-HBs-reactive, and 11 were anti-HBc only. The analyse of risk factors showed that age 16-19 years, place of birth outside Goiás, school B and body piercing were statistically associated with HBV infection markers (p < 0.05). All 170 adolescents responded to Butang, and a geometric mean titer (gmt) of 4344 mUI/ml was obtained. these results reinforce the importance of hepatitis b vaccine in adolescents despite of the hbv regional endemicity, and suggest that three doses of 20 microg of the Butang should guarantee protective anti-hbs levels to individuals at a critical time for hepatitis b acquiring such as latter adolescence and adulthood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16862317     DOI: 10.1590/s0074-02762006000300004

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  3 in total

1.  The prevalence of hepatitis B virus markers in a cohort of students in Bangui, Central African Republic.

Authors:  Narcisse P Komas; Souleyman Baï-Sepou; Alexandre Manirakiza; Josiane Léal; Aubin Béré; Alain Le Faou
Journal:  BMC Infect Dis       Date:  2010-07-29       Impact factor: 3.090

2.  Comparison of epidemiological methods for estimation of hepatitis B incidence and residual risk for blood donors in southern Brazil.

Authors:  Emil Kupek; Andrea Petry
Journal:  J Transfus       Date:  2011-05-10

3.  Effectiveness of DNA-recombinant anti-hepatitis B vaccines in blood donors: a cohort study.

Authors:  Emil Kupek; Denise E R de Souza; Andrea Petry
Journal:  BMC Infect Dis       Date:  2007-11-06       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.